REGINA LEE: Open Payments
NPI 1487787461 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,706 in 83 payments from 24 companies in 2025. Trend: 2023 $2,661 · 2024 $2,716 · 2025 $1,706
Food & beverage: $1,706
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $371 |
| Amgen Inc. | 13 | $201 |
| Abbott Laboratories | 2 | $157 |
| AstraZeneca Pharmaceuticals LP | 10 | $157 |
| Phathom Pharmaceuticals, Inc. | 2 | $153 |
| ABBVIE INC. | 4 | $95 |
| SANOFI-AVENTIS U.S. LLC | 4 | $84 |
| PFIZER INC. | 3 | $48 |
| Janssen Pharmaceuticals, Inc | 1 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
Products named: VOQUEZNA, XIENCE SKYPOINT, Ozempic, TZIELD, OTEZLA, Rybelsus, BREZTRI, REPATHA.
Industry payments across TX — which companies pay providers there.
